Article Versions Notes

Chen C-H, Lee H-H, Chuang H-Y, Hung J-Y, Huang M-Y, Chong I-W. Combination of Whole-Brain Radiotherapy with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Improves Overall Survival in EGFR-Mutated Non-Small Cell Lung Cancer Patients with Brain Metastases. Cancers. 2019; 11(8):1092. https://doi.org/10.3390/cancers11081092

Chen, Chien-Hung, Hsin-Hua Lee, Hung-Yi Chuang, Jen-Yu Hung, Ming-Yii Huang, and Inn-Wen Chong. 2019. "Combination of Whole-Brain Radiotherapy with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Improves Overall Survival in EGFR-Mutated Non-Small Cell Lung Cancer Patients with Brain Metastases" Cancers 11, no. 8: 1092. https://doi.org/10.3390/cancers11081092

Chen, C.-H., Lee, H.-H., Chuang, H.-Y., Hung, J.-Y., Huang, M.-Y., & Chong, I.-W. (2019). Combination of Whole-Brain Radiotherapy with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Improves Overall Survival in EGFR-Mutated Non-Small Cell Lung Cancer Patients with Brain Metastases. Cancers, 11(8), 1092. https://doi.org/10.3390/cancers11081092